MX9100018A - Histidinas sustituidas - Google Patents
Histidinas sustituidasInfo
- Publication number
- MX9100018A MX9100018A MX9100018A MX9100018A MX9100018A MX 9100018 A MX9100018 A MX 9100018A MX 9100018 A MX9100018 A MX 9100018A MX 9100018 A MX9100018 A MX 9100018A MX 9100018 A MX9100018 A MX 9100018A
- Authority
- MX
- Mexico
- Prior art keywords
- histidins
- substituted
- substituted histidins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54525390A | 1990-06-28 | 1990-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9100018A true MX9100018A (es) | 1992-02-03 |
Family
ID=24175483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9100018A MX9100018A (es) | 1990-06-28 | 1991-06-28 | Histidinas sustituidas |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5444081A (es) |
| EP (1) | EP0536262A4 (es) |
| JP (1) | JPH05508642A (es) |
| KR (1) | KR930701411A (es) |
| AU (1) | AU650890B2 (es) |
| CA (1) | CA2084776A1 (es) |
| IE (1) | IE912248A1 (es) |
| MX (1) | MX9100018A (es) |
| NZ (1) | NZ238688A (es) |
| PT (1) | PT98143A (es) |
| WO (1) | WO1992000068A1 (es) |
| ZA (1) | ZA914960B (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5073566A (en) * | 1989-11-30 | 1991-12-17 | Eli Lilly And Company | Angiotensin ii antagonist 1,3-imidazoles and use thereas |
| NZ238688A (en) * | 1990-06-28 | 1992-05-26 | Smithkline Beecham Corp | Substituted histidines: pharmaceutical compositions, preparation and uses thereof |
| NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
| TW215434B (es) * | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
| GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
| US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
| FR2770538B1 (fr) * | 1997-11-06 | 2000-10-13 | Bio Merieux | Procede et agent de detection et d'identification et/ou quantification d'une activite enzymatique de type desaminase |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| DE602004024879D1 (de) | 2003-04-29 | 2010-02-11 | Univ Zuerich | AN EINEM BIOMOLEKÜL GEBUNDENEN N epsilon- UND/ODER N alpha DERIVATISIERTEM UND ORGANISCH-GESCHÜTZTEM L-HISTIDIN ZUR HOCH-EFFIZIENTER MARKIERUNG MIT (M(H2O)3(CO)3)+ MITTELS FAC KOORDINIERUNG |
| WO2005086836A2 (en) * | 2004-03-08 | 2005-09-22 | Wyeth | Ion channel modulators |
| TW201018662A (en) * | 2005-12-12 | 2010-05-16 | Astrazeneca Ab | Alkylsulphonamide quinolines |
| TWI448284B (zh) * | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2393885T7 (es) | 2007-06-04 | 2014-01-30 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| EP2297113A1 (en) | 2008-04-29 | 2011-03-23 | Theravance, Inc. | Dual-acting antihypertensive agents |
| WO2009149279A2 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| JP2011529072A (ja) | 2008-07-24 | 2011-12-01 | セラヴァンス， インコーポレーテッド | 二重作用血圧降下薬 |
| TW201014830A (en) * | 2008-09-30 | 2010-04-16 | Theravance Inc | Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| JP5833000B2 (ja) | 2009-07-07 | 2015-12-16 | セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー | 二重に作用するピラゾール抗高血圧症薬 |
| ES2441419T3 (es) | 2009-07-22 | 2014-02-04 | Theravance, Inc. | Agentes antihipertensivos de doble acción basados en oxazol |
| EP2526095A1 (en) | 2010-01-19 | 2012-11-28 | Theravance, Inc. | Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| EP2986293A1 (en) | 2013-04-19 | 2016-02-24 | Astrazeneca AB | A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos) |
| EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4215217A (en) * | 1975-10-29 | 1980-07-29 | Sk&F Lab Co. | Process for preparing 4-substituted imidazole compounds |
| FI803127A7 (fi) * | 1979-10-03 | 1981-04-04 | Glaxo Group Ltd | Heterosyklisiä yhdisteitä. |
| JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| JPS5671073A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | Imidazole derivative |
| US4348404A (en) * | 1980-07-21 | 1982-09-07 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-α-polyfluoroalkyl-1H-imidazole-2-methanamines |
| US4404387A (en) * | 1980-09-17 | 1983-09-13 | The Upjohn Company | Aminoalkyl-substituted imidazoles |
| GB2110663B (en) * | 1981-12-04 | 1985-08-07 | Farmos Group Ltd | Imidazole derivatives |
| JPS58157768A (ja) * | 1982-03-16 | 1983-09-19 | Takeda Chem Ind Ltd | ４−クロロ−２−フエニルイミダゾ−ル−５−酢酸誘導体 |
| DK36584A (da) * | 1983-02-15 | 1984-08-16 | Hoffmann La Roche | Imidazolderivater |
| US4812462A (en) * | 1986-04-01 | 1989-03-14 | Warner-Lambert Company | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4996221A (en) * | 1987-01-13 | 1991-02-26 | The Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives as immune modulators |
| US4898878A (en) * | 1987-10-02 | 1990-02-06 | The Board Of Regents Of The University Of Washington | Antioxidant thiohistidine compounds |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| FR2630328B1 (fr) * | 1988-04-22 | 1990-08-24 | Inst Nat Sante Rech Med | Derive de l'histamine, sa preparation et son application en therapeutique |
| CA2018443A1 (en) * | 1989-06-14 | 1990-12-14 | Joseph A. Finkelstein | Imidazolyl-alkenoic acids |
| ATE190051T1 (de) * | 1989-06-14 | 2000-03-15 | Smithkline Beecham Corp | Imidazoalkensäure |
| CA2027937A1 (en) * | 1989-10-25 | 1991-04-26 | Richard M. Keenan | Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles |
| CA2028925A1 (en) * | 1989-11-06 | 1991-05-07 | Gerald R. Girard | Substituted n-(imidazolyl)alkyl alanine derivatives |
| US4989878A (en) * | 1989-12-18 | 1991-02-05 | Davies Robert R | Wheel word game |
| CA2032289A1 (en) * | 1989-12-29 | 1991-06-30 | Joseph A. Finkelstein | Substituted 5-(alkyl) carboxamide imidazoles |
| US5234917A (en) * | 1989-12-29 | 1993-08-10 | Finkelstein Joseph A | Substituted 5-(alkyl)carboxamide imidazoles |
| NZ238688A (en) * | 1990-06-28 | 1992-05-26 | Smithkline Beecham Corp | Substituted histidines: pharmaceutical compositions, preparation and uses thereof |
| GB9027200D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027212D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| US5159083A (en) * | 1990-12-28 | 1992-10-27 | Neurogen Corporation | Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands |
| US5191086A (en) * | 1991-03-19 | 1993-03-02 | E.R. Squibb & Sons, Inc. | Imidazole and benzimidazole derivatives |
-
1991
- 1991-06-25 NZ NZ238688A patent/NZ238688A/en unknown
- 1991-06-26 CA CA002084776A patent/CA2084776A1/en not_active Abandoned
- 1991-06-26 WO PCT/US1991/004561 patent/WO1992000068A1/en not_active Ceased
- 1991-06-26 AU AU81059/91A patent/AU650890B2/en not_active Expired - Fee Related
- 1991-06-26 KR KR1019920703381A patent/KR930701411A/ko not_active Withdrawn
- 1991-06-26 JP JP91511951A patent/JPH05508642A/ja active Pending
- 1991-06-26 US US07/965,370 patent/US5444081A/en not_active Expired - Fee Related
- 1991-06-26 EP EP91912453A patent/EP0536262A4/en not_active Withdrawn
- 1991-06-27 ZA ZA914960A patent/ZA914960B/xx unknown
- 1991-06-27 IE IE224891A patent/IE912248A1/en unknown
- 1991-06-28 PT PT98143A patent/PT98143A/pt not_active Application Discontinuation
- 1991-06-28 MX MX9100018A patent/MX9100018A/es unknown
-
1995
- 1995-05-02 US US08/434,333 patent/US5565480A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU8105991A (en) | 1992-01-23 |
| ZA914960B (en) | 1992-07-29 |
| NZ238688A (en) | 1992-05-26 |
| US5565480A (en) | 1996-10-15 |
| KR930701411A (ko) | 1993-06-11 |
| PT98143A (pt) | 1992-04-30 |
| CA2084776A1 (en) | 1991-12-29 |
| AU650890B2 (en) | 1994-07-07 |
| EP0536262A4 (en) | 1996-08-14 |
| JPH05508642A (ja) | 1993-12-02 |
| WO1992000068A1 (en) | 1992-01-09 |
| IE912248A1 (en) | 1992-01-01 |
| US5444081A (en) | 1995-08-22 |
| EP0536262A1 (en) | 1993-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69119415D1 (de) | Mitralklappenersatz | |
| DK0439279T3 (da) | Borerørs-/foringsbeskyttelsesorgan | |
| FI925335A0 (fi) | Pulsresponsanordning | |
| FI931745L (fi) | Tvaofasiga avgivningsformulationer foer lipofiliska laekemedel | |
| FI930077L (fi) | Oxamider | |
| FI925031L (fi) | Iontoforetisk administreringsanordning | |
| FI930254A7 (fi) | Anordning foer informationsoeverfoering | |
| FI932150A7 (fi) | Analyssystem foer glykerande blodproteiner | |
| FI932772L (fi) | Solvaterad mesofasbeck | |
| FI924971A0 (fi) | Pressvals | |
| FI931169L (fi) | Foerbaettrade vaccinkompositioner | |
| FI925987A0 (fi) | Vattenrengoeringsprocess | |
| FI932054A0 (fi) | Aggregerade mineralkompositpigment | |
| MX9100018A (es) | Histidinas sustituidas | |
| FI932680A0 (fi) | Fusionspolypeptider | |
| DE69119844D1 (de) | Chiffriergerät | |
| FI924204A7 (fi) | Faestanordning foer utbyteskort | |
| FI931911A0 (fi) | Passageoevervakningsanordning | |
| ITMI911945A0 (it) | Liccio | |
| FI925545A0 (fi) | Bensoesyraderivat | |
| FI930382L (fi) | Portioneringsanordning foer drycker | |
| FI925426A0 (fi) | Flytande antiperspirantkompositioner | |
| FI932593A0 (fi) | Vaevnad foer en pappersmaskin | |
| BR9102325A (pt) | Ebulidor | |
| FI924203L (fi) | Betalningsaktiverad aotergivningsautomat |